Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Now That Pharmasset and Achillion Have Received Takeover Bids; Is Achillion Next? (ACHN, $9.72)

Following the announcement that Gilead was proposing to acquire Pharmasset (VRUS), I postulated in a note written on November 11,…
Read more…

Achillion Could Be On Big Pharma's Acquisition List (ACHN, $6.00)

Gilead (GILD) is certainly paying up for Pharmasset with its offer to buy the company at $137 per share ($11…
Read more…

Gilead Makes Bid for Pharmasset: Could Achillion Be Next in Big Pharma's Acquisition Gun Sights (ACHN, $6.00)

Gilead (GILD) is certainly paying up for Pharmasset with its offer to buy the company at $137 per share ($11…
Read more…